TensorWave Secures $100 Million Series A Funding Co-Led by Magnetar and AMD Ventures

LAS VEGAS--(BUSINESS WIRE)--May 14, 2025--

TensorWave, the emerging leader in AMD-powered AI infrastructure solutions, today announced it has raised $100 million in Series A funding. Magnetar and AMD Ventures led the round, with continued support from Maverick Silicon, Nexus Venture Partners, and new investor Prosperity7. This funding builds on the company's earlier SAFE round and positions TensorWave to capitalize on the growing demand for next-gen AI compute infrastructure.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250514340458/en/

The investment aligns with TensorWave's deployment of over 8,000 AMD Instinct™ MI325X GPUs for a dedicated training cluster, establishing the company as a key player in the AI infrastructure ecosystem. TensorWave is on track to close the year with a revenue run rate exceeding $100 million — a 20x year-over-year increase.

"This $100M funding propels TensorWave's mission to democratize access to cutting-edge AI compute," said Darrick Horton, CEO of TensorWave. "Our 8,192 Instinct MI325X GPU cluster marks just the beginning as we establish ourselves as the emerging AMD-powered leader in the rapidly expanding AI infrastructure market.”

The new capital will fuel TensorWave’s operational growth, team expansion, and the accelerated deployment of its Instinct MI325X-powered training cluster. This growth comes at a pivotal moment, as demand for AI computing resources continues to outstrip supply and organizations seek alternatives to limited infrastructure options.

“The $100 million we've secured will transform how enterprises access AI computing resources," said Piotr Tomasik, President of TensorWave. "Through careful cultivation of strategic partnerships and investor relationships, we've positioned TensorWave to solve the critical infrastructure bottleneck facing AI adoption. Our Instinct MI325X cluster deployment isn't just about adding capacity, it's about creating an entirely new category of enterprise-ready AI infrastructure that delivers both the memory headroom and performance reliability that next-generation models demand.”

“Our focus is to continue to expand the ecosystem and support developers with the tools, infrastructure, and performance they need to create, scale, and ship production-ready AI,” shares Jeff Tatarchuk, TensorWave’s Chief Growth Officer.

AMD Ventures’ strategic investment in TensorWave reinforces the commitment of AMD to expand its footprint in the AI infrastructure space and ensures its latest technologies are available in the cloud and at-scale for leading AI companies and enterprises.

“TensorWave is a key player in the growing AMD AI ecosystem,” said Mathew Hein, SVP Chief Strategy Officer & Corporate Development, AMD. “Their expanding portfolio of AI and enterprise customers coupled with their expertise in deploying AMD compute infrastructure is driving demand for access to their cutting-edge AI compute services. We're excited to support their next phase of growth.”

“We continue to be highly impressed by what the TensorWave team has built in just a short period of time. TensorWave is not just bringing more compute but rather an entirely new class of compute to a capacity-constrained market. We think this will be highly beneficial to the AI infrastructure ecosystem writ large, and we’re thrilled to continue our support of the company,” said Kenneth Safar, Managing Director at Maverick Silicon.

The funding comes at a time when the AI infrastructure market is experiencing unprecedented growth, with recent industry reports projecting the AI infrastructure market to exceed $400 billion by 2027. TensorWave's focus on technology-powered solutions and continued partnerships with firms like TECFusions positions the company to capture a significant portion of this expanding market.

For additional information please visit: https://tensorwave.com.

About TensorWave

TensorWave is the AI and HPC cloud purpose-built for performance. Powered exclusively by AMD Instinct™ Series GPUs, we deliver high-bandwidth, memory-optimized infrastructure that scales with your most demanding models—training or inference. For more information please visit https://tensorwave.com.

TensorWave Secures $100 Million Series A Funding Co-Led by Magnetar and AMD Ventures. Funding Fuels Rapid Deployment of Massive AMD Instinct MI325X GPU Training Cluster and Supports Scaling for Surging AI Infrastructure Needs

WOODBRIDGE, Conn.--(BUSINESS WIRE)--Jan 12, 2026--

ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market. To support its growth in the region, ChemWerth has hired Chandrakanth Reddy as general sales manager of its India office.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260111302280/en/

“The addition of a general sales manager in India signals our desire to grow our presence and customer base in the world’s most important generic pharmaceutical market,” said Pete Werth III, president, ChemWerth. “Chandrakanth will add tremendous value for our customers and contract manufacturing organizations (CMOs) in India.”

Reddy is a seasoned pharmaceutical professional with more than 16 years of experience spanning API sourcing, business development, market expansion and regulatory-driven commercial strategy. He has successfully led high-value markets across India, the Middle East, North Africa, Europe, and the United States, building strong customer partnerships and supporting sustainable revenue growth.

In his new role, Reddy will be responsible for leading ChemWerth’s sales strategy in India and strengthening regional customer relationships. He will also support the company’s focused initiative to roll out new generic APIs in the market, including fermentation, peptide and oncology injectable APIs.

“After reviewing ChemWerth’s strategic plan to unveil a strong pipeline of new generic fermentation, peptide and oncology injectable APIs for the Indian market, I knew that was something I wanted to be a part of,” said Reddy.

About ChemWerth, Inc.:

Established in 1982, ChemWerth is a full-service generic active pharmaceutical ingredient (API) development and supply company providing cGMP-quality APIs to regulated markets worldwide. ChemWerth is a global company headquartered in the United States, with offices in China and India. For more information, please visit www.chemwerth.com.

Chandrakanth Reddy has joined ChemWerth, Inc., as general sales manager of its India office.